Biological Sample Collection Kits Market Outlook:
Biological Sample Collection Kits Market size was valued at USD 9.84 billion in 2025 and is expected to reach USD 22.66 billion by 2035, registering around 8.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of biological sample collection kits is evaluated at USD 10.61 billion.
The recent trends in sample testing and personalized medicine are expected to boost the growth of the biological sample collection kits market. The increasing awareness of early disease detection and the rise in incidence rates for chronic diseases have been growing, leading to an increased demand for efficient sample collection methods. Furthermore, an increase in in-home medical care solutions represents a significant opportunity for market growth, as these kits enable the easy and accurate collection of samples outside traditional clinical settings.
To strengthen their market presence, key players in the biological sample collection kits market are focused on product innovation and strategic collaborations. In March 2023, Cue Health introduced a family of at-home diagnostic test kits that allow users to take control with reliable and private sample collection. In addition, growing investment from governments across the globe is expected to boost advanced biological sample collection methods. In December 2023, the FDA issued a 510(k) clearance to BD's MiniDraw Capillary Blood Collection System, which offers blood sample collection with less invasiveness as an example. The approval showcases the role of government in promoting the wide availability of patients with innovative care solutions and consequently improved patient outcomes.
